Physician profile
Amber Bock
NPI 1770822074
$3,483.77
in general payments reported to CMS, 2019-2025
25 companies · $720 in 2025
The $720 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $322 · 2022: $744 · 2023: $1,077 · 2024: $620 · 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,418.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $910.80 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Abbott Laboratories | $354.43 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $311.51 | 2022-2025 | |
| Pfizer INC. | $258.35 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $223.01 | 2022-2025 | Lifevest |
| Novo Nordisk INC | $168.61 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $166.18 | 2022-2023 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $155.10 | 2021-2025 | Farxiga |
| Kiniksa Pharmaceuticals, Ltd. | $134.37 | 2023 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $128.16 | 2021-2025 | Eliquis |
| Boston Scientific Corporation | $96.05 | 2025 | Watchman |
| Biotronik INC. | $93.83 | 2022-2025 | Biomonitor, Acticor 7 Vr-T Dx |
| Bayer Healthcare Pharmaceuticals INC. | $89.37 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.53 | 2023-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $65.33 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $43.38 | 2021-2024 | Zio Monitor, Zio Xt Patch |
| Mentor Worldwide LLC | $41.31 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abiomed | $37.39 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $24.52 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $21.01 | 2024 | |
| United Therapeutics Corporation | $19.89 | 2021 | |
| Sandoz INC. | $17.19 | 2023 | Treprostinil |
| Lilly USA, LLC | $17.01 | 2025 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $15.84 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Bock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.